臺灣博碩士論文加值系統

本論文主要分為兩個部分: 第一部份以香豆素衍生物為起始物製備新型雜環化合物經由分子內 Wittig 反應； 第二部份發展有機催化 Michael 加成反應，以香豆素衍生物作為 Michael 受體與環己酮或丙醛進行反應。
第一部份，設計三種香豆素衍生物作為 Michael 受體與醯氯、三丁基膦以及三乙基胺進行分子內 Wittig 反應，合成多官能性的呋喃[3,4-c]香豆素、呋喃[3,2-c]香豆素以及具有呋喃分子取代的香豆素化合物。
第二部分，設計具有 Michael 受體的香豆素衍生物，以香豆素衍生物為起始物與環己酮、丙醛進行有機催化 Michael 加成反應，合成以香豆素為主結構的一種新型的 Michael 加成產物，具高立體選擇性 (非鏡像選擇性 20:1，鏡像超越值 91% ee ) 以及良好的產率 80%。如果將環己酮置換為丙醛，以丙醛與 具 Michael 受體的香豆素衍生物進行有機催化 Michael 加成反應，得到的 Michael 加成產物可進一步與 PCC 進行氧化反應，產物為新類型且具兩個掌性中心的多官能性內酯衍生物。

The dissertation is divided into two parts: preparation of new types of heterocycles bearing coumarin moieties via intramolecular Wittig reactions as key steps (part I) and development of organocatalytic Michael addition reactions of cyclohexanone or propionaldehyde towards the designed Michael acceptors with coumarin moieties (part II).
In part I, three kinds of designed coumarin derivatives as Michael acceptors are proposed and successfully react with a wide variety of acid chlorides, tributylphosphine, and triethylamine via intramolecular Wittig reactions to provide functional furo[3,4-c]coumarins, furo[3,2-c]coumarins, and furyl coumarins (Figure 1).
In part II, investigation of organocatalytic Michael addition reactions of cyclohexanone or propionaldehyde towards the designed Michael acceptors with coumarin moieties is carried out. A new type of Michael adducts with high stereoselectivities (up to 20:1 dr, 91% ee) and good yields (up to 80% yield) can be generated starting from cyclohexanone and Michael acceptors with coumarin as the core structure. While propionaldehyde, instead of cyclohexanone, is employed in organocatalytic Michael addition reactions with Michael acceptors bearing coumarin moieties, the Michael adducts can further undergo oxidation reactions with PCC to afford a new class of functional lactone derivatives with two stereogenetic centers.

摘 要 III
Abstract IV
目 錄 V
第一章 經由分子內 Wittig 反應合成呋喃香豆素和具有呋喃取代的香豆素分子 2
1-1 前言 2
1-2 呋喃香豆素合成方法及文獻探討 5
1-2-1 在香豆素上建構呋喃環 5
1-2-2 在苯并呋喃上建構吡喃環 10
1-2-3 同時建構呋喃環以及吡喃環 12
1-3 研究動機 15
1-4實驗結果與討論 18
1-4-1 使用香豆素為起始物合成呋喃[3,4-c]香豆素產物 18
1-4-2 具有位向選擇性的起始物合成具呋喃取代的香豆素產物 23
1-4-3 使用香豆素的 4 號位有羥基的香豆素起始物進行反應 26
1-5 結論 36
1-6未來展望 36
1-7實驗部分 37
1-7-1分析儀器及基本實驗操作 37
附錄一 39

(1) Schiedel, M.-S.; Briehn, C. A.; Bäuerle, P. Angew. Chem. Int. Ed. 2001, 40, 4677.
(2) Inagaki, S.; Ohtani, O.; Goto, Y.; Okamoto, K.; Ikai, M.; Yamanaka, K.-i.; Tani, T.; Okada, T. Angew. Chem. Int. Ed. 2009, 48, 4042.
(3) M. E. Riveiro, N. D. K., A. Moglioni, R. Vazquez, F. Monczor, C. Shayo, C. Davio Curr. Med. Chem 2010, 17, 1325.
(4) Kathuria, A.; Priya, N.; Chand, K.; Singh, P.; Gupta, A.; Jalal, S.; Gupta, S.; Raj, H. G.; Sharma, S. K. Bioorg. Med. Chem. 2012, 20, 1624.
(5) Carta, F.; Maresca, A.; Scozzafava, A.; Supuran, C. T. Bioorg. Med. Chem. 2012, 20, 2266.
(6) Sashidhara, K. V.; Kumar, A.; Kumar, M.; Sarkar, J.; Sinha, S. Bioorg. Med. Chem. Lett. 2010, 20, 7205.
(7) Saidu, N. E. B.; Valente, S.; Bana, E.; Kirsch, G.; Bagrel, D.; Montenarh, M. Bioorg. Med. Chem. 2012, 20, 1584.
(8) L. Santana*a, E. U. a., F. Roleirab, N. Milhazesc and F. Borgesc Curr. Med. Chem. 2004, 11, 3239.
(9) Piccagli, L.; Borgatti, M.; Nicolis, E.; Bianchi, N.; Mancini, I.; Lampronti, I.; Vevaldi, D.; Dall’Acqua, F.; Cabrini, G.; Gambari, R. Bioorg. Med. Chem. 2010, 18, 8341.
(10) Girennavar, B.; Jayaprakasha, G. K.; Jadegoud, Y.; Nagana Gowda, G. A.; Patil, B. S. Bioorg. Med. Chem. 2007, 15, 3684.
(11) Lapolla, W.; Yentzer, B. A.; Bagel, J.; Halvorson, C. R.; Feldman, S. R. J Am Acad Dermatol 2011, 64, 936.
(12) Dalla Via, L.; Gia, O.; Caffieri, S.; García-Argáez, A. N.; Quezada, E.; Uriarte, E. Bioorg. Med. Chem.
(13) Santana, L.; Uriarte, E.; Dalla Via, L.; Gia, O. Bioorg. Med. Chem. Lett. 2000, 10, 135.
(14) Dalla Via, L.; Mammi, S.; Uriarte, E.; Santana, L.; Lampronti, I.; Gambari, R.; Gia, O. J. Med. Chem. 2006, 49, 4317.
(15) Cheng, G.; Hu, Y. Chem. Commun. 2007, 3285.
(16) Cheng, G.; Hu, Y. J. Org. Chem. 2008, 73, 4732.
(17) Tang, L.; Pang, Y.; Yan, Q.; Shi, L.; Huang, J.; Du, Y.; Zhao, K. J. Org. Chem 2011, 76, 2744.
(18) Jia, C.; Piao, D.; Kitamura, T.; Fujiwara, Y. J. Org. Chem 2000, 65, 7516.
(19) Hon, Y.-S.; Tseng, T.-W.; Cheng, C.-Y. Chem. Commun. 2009, 5618.
(20) Tetrahedron Lett. 1995, 36, 7109.
(21) Dinker I. Brahmbhatt*, J. M. G., Chirag N. Patel, Vishwesh P. Pandya; Pandya, a. U. R. J. Heterocycl. Chem. 2006, 43, 1699.
(22) Kao, T.-T.; Syu, S.-e.; Jhang, Y.-W.; Lin, W. Org. Lett. 2010, 12, 3066.
(23) Chen, K.-W.; Syu, S.-e.; Jang, Y.-J.; Lin, W. Org. Biomol. Chem. 2011, 9, 2098.
(24) Raju, B. C.; Tiwari, A. K.; Kumar, J. A.; Ali, A. Z.; Agawane, S. B.; Saidachary, G.; Madhusudana, K. Bioorg. Med. Chem. 2010, 18, 358.
(25) Hazai, E.; Visy, J.; Fitos, I.; Bikádi, Z.; Simonyi, M. Bioorg. Med. Chem. 2006, 14, 1959.
(26) Lu, Y.; Arndtsen, B. A. Org. Lett. 2009, 11, 1369.